Sunshine Guojian Pharmaceutical (shanghai) Co., Ltd. Class ASSE: 688336

Announcement on Voluntary Disclosure of the Approval of the New Drug Marketing Application for Anmuqita Monoclonal Antibody Injection

· Issued by Sunshine Guojian Pharmaceutical (shanghai) Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of the Approval of the New Drug Marketing Application for Anmuqita Monoclonal Antibody Injection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis